Lei‐Lei Wu

机构：Tongji University, Sun Yat-sen University, Chinese Academy of Sciences, Zhejiang Cancer Hospital, Shanghai Pulmonary Hospital, Shanghai Tenth People's Hospital, Sun Yat-sen University Cancer Center, Hangzhou Cancer Hospital · ORCID：0000-0002-7417-6864

发表论文 79 篇 · 总被引 1112 次 · h-index 15

代表论文

• Apoptosis and cuproptosis Co-activated Copper-based metal-organic frameworks for cancer therapy (2024 · Journal of Nanobiotechnology · 被引 59)
• Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma (2024 · Nature Communications · 被引 48)
• Glucose Deprivation‐Induced Disulfidptosis via the SLC7A11‐INF2 Axis: Pan‐Cancer Prognostic Exploration and Therapeutic Validation (2025 · Advanced Science · 被引 14)
• High-risk characteristics of pathological stage I lung adenocarcinoma after resection: patients for whom adjuvant chemotherapy should be performed (2023 · Heliyon · 被引 12)
• Validation of the 9th edition of the TNM staging system for non-small cell lung cancer with lobectomy in stage IA–IIIA (2024 · European Journal of Cardio-Thoracic Surgery · 被引 10)
• Regulation of cGAS-STING pathway with inhalable nanozyme in acute lung injury (2025 · Biomaterials · 被引 9)